GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (LTS:0IL8) » Definitions » Issuance of Stock

FibroGen (LTS:0IL8) Issuance of Stock : $17.7 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is FibroGen Issuance of Stock?

FibroGen's Issuance of Stock for the three months ended in Mar. 2024 was $0.0 Mil.

FibroGen's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was $17.7 Mil.


FibroGen Issuance of Stock Historical Data

The historical data trend for FibroGen's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen Issuance of Stock Chart

FibroGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.78 37.83 - - 48.41

FibroGen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.75 17.66 - - -

FibroGen Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroGen Issuance of Stock Related Terms

Thank you for viewing the detailed overview of FibroGen's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroGen (LTS:0IL8) Business Description

Traded in Other Exchanges
Address
409 Illinois Street, San Francisco, CA, USA, 94158
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen (LTS:0IL8) Headlines

No Headlines